Ann M. Rowland

Humanization of an anti-p185HER2 antibody for human cancer therapy.

Paul Carter, Leonard G. Presta, C Gorman et al. · Proceedings of the National Academy of Sciences · 1992 · 1.9K citations · Full text

Anti-p185her2 Antibody, Tumor Targeting, Immunology +13

Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

Keith A. Houck, David W. M. Leung, Ann M. Rowland et al. · Journal of Biological Chemistry · 1992 · 1.1K citations · Full text

Inflammation, Developmental Biology, Angiogenesis +15

High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment

Paul Carter, Robert F. Kelley, Maria Luı́sa Rodrigues et al. · Nature Biotechnology · 1992 · 330 citations

Engineering, Biotechnology, Synthetic Biology +8

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.

Napoleone Ferrara, Jane Winer, Theresa Burton et al. · Journal of Clinical Investigation · 1993 · 167 citations · Full text

Growth Advantage, Developmental Biology, Angiogenesis +14

Ligand-Mediated Immunofunctional Assay for Quantitation of Growth Hormone-Binding Protein in Human Blood

Lena Carlsson, Ann M. Rowland, Ross Clark et al. · The Journal of Clinical Endocrinology & Metabolism · 1991 · 129 citations

Immunocytochemical Technique, Immunology, Pathology +20